| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6146
|
195.00 | 19.9B | 4.27 | 3.72 | 2.35 | 48.5% | 12.0% | 88 | 85 | 381.14 | +71.6% | 89 | 0.02 |
|
9917
|
106.00 | 49.4B | 4.05 | 3.74 | 2.91 | 16.3% | 10.7% | 85 | 72 | 202.53 | +68.3% | 81 | 0.63 |
|
3587
|
247.00 | 17.1B | 9.08 | 2.88 | 1.80 | 15.0% | 11.0% | 76 | 70 | 439.23 | +58.4% | 84 | 0.35 |
|
6257
|
198.50 | 94.9B | 5.81 | 3.74 | 2.81 | 13.6% | 10.0% | 76 | 68 | 337.43 | +52.5% | 83 | 0.57 |
|
3265
|
178.00 | 24.3B | 6.24 | 3.84 | 3.38 | 13.0% | 11.1% | 74 | 65 | 284.65 | +44.9% | 85 | 0.46 |
|
3264
|
228.00 | 108.1B | 7.19 | 5.51 | 4.12 | 10.9% | 10.0% | 68 | 61 | 322.39 | +31.1% | 71 | 0.79 |
|
2449
|
257.00 | 330.0B | 8.84 | 5.27 | 4.59 | 9.5% | 9.2% | 65 | 60 | 339.13 | +24.0% | 73 | 0.67 |
|
6937
|
282.00 | 19.0B | 15.53 | 5.35 | 11.85 | 8.5% | 11.7% | 38 | 28 | 138.54 | -38.2% | 84 | 0.21 |
|
6830
|
520.00 | 28.3B | 100.00 | 8.33 | 9.40 | 1.0% | 11.3% | 36 | 38 | 341.32 | -24.7% | 67 | 0.77 |
|
2258
|
31.10 | 54.5B | — | 4.80 | — | -23.9% | 11.0% | 27 | 11 | 13.79 | -24.0% | 45 | 0.60 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.